Berlin-based AMBOSS, a leading platform for medical education and clinical decision-making, has raised €240 million in fresh funding to accelerate its global expansion and broaden its offerings to include nurses and additional healthcare professionals.
The round includes new long-term investors such as KIRKBI, M&G Investments, and Lightrock, alongside existing backers. To facilitate the raise, AMBOSS transitioned to a European stock corporation (SE).
Scaling Global Impact in Healthcare
Founded in 2012 by physicians Dr. Madjid Salimi and Benedikt Hochkirchen, the company provides an interactive medical knowledge library and question bank for students, along with evidence-based diagnostic and treatment guidance for clinicians.
Used by over 1 million professionals in 180 countries, the platform aims to streamline decision-making, reduce errors, and support medical training. In Germany, half of all inpatient treatments involve AMBOSS, while in the U.S., it’s widely adopted for exam prep and clinical support, especially by first-year residents.
Advertisement
Leveraging AI to Empower Care
AMBOSS integrates AI-driven tools to ensure real-time, accurate recommendations aligned with current guidelines. “Technology won’t replace healthcare professionals, but those who embrace it will lead,” said Dr. Salimi.
The company now employs 500+ staff, including 150 physicians, scientists, and engineers.
Strategic Vision and Use of Funds
Co-CEO Benedikt Hochkirchen emphasized that the funding will:
- Fuel global expansion, particularly in the U.S. and new markets
- Advance its AI and platform capabilities
- Extend services to nurses and broader medical roles
- Support strategic acquisitions, following its 2024 purchases of Novaheal (nursing education) and NEJM Knowledge+ (board exam prep)
Many new backers operate evergreen funds, supporting AMBOSS through a potential future IPO and beyond.
With €240M in new capital, the company is poised to become a cornerstone platform in global healthcare, bridging clinical knowledge with cutting-edge technology.
